NCT02407145View on ClinicalTrials.gov

Safety and Efficacy of PVDF (DynaMesh®-SIS Soft) Retropubic Midurethral Slings in Stress Urinary Incontinence in Women

CompletedOBSERVATIONAL
Enrollment

218

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 1, 2021

Study Completion Date

April 1, 2021

Conditions
Urinary Stress IncontinenceUrinary Incontinence,Stress
Interventions
OTHER

24 month follow up of women with validated questionnaire

24 month follow up (clinical and questionnaire based) of women who are already assigned to have a PVDF retropubic midurethral sling (DynaMesh®-SIS soft) as a part of their planned treatment of urodynamic stress incontinence.

Trial Locations (10)

81679

Chirurgische Klinik, Munich

97080

Universitätsklinikum Würzburg, Würzburg

PE29 6NT

Hichingbooke Hospital, Huntingdon

CB2 0QQ

Addenbrooke's Hospital, Cambridge

BT16 1RH

South Eastern Health and Social Care Trust, Belfast

KA2 0BE

NHS Ayrshire & Arran, Kilmarnock

NW1 2BU

University College Hospital, London

CH49 5PE

Wirral University Teaching Hospital NHS Foundation, Metropolitan Borough of Wirral

NR4 7UY

Norfolk and Norwich University Hospitals Trust, Norwich

B91 1PS

Heart of England NHS Foundation Trust, Solihull

All Listed Sponsors
collaborator

Kebomed UK

UNKNOWN

lead

Julie Dawson

OTHER

NCT02407145 - Safety and Efficacy of PVDF (DynaMesh®-SIS Soft) Retropubic Midurethral Slings in Stress Urinary Incontinence in Women | Biotech Hunter | Biotech Hunter